Literature DB >> 2585248

Cutaneous delayed-type hypersensitivity in patients with human immunodeficiency virus infection in Zaire.

R L Colebunders1, I Lebughe, N Nzila, D Kalunga, H Francis, R Ryder, P Piot.   

Abstract

Cutaneous delayed-type hypersensitivity (DTH) reactions were assessed by the CMI-Multitest (Merieux, Lyon, France) in patients with different stages of human immunodeficiency virus (HIV) infection in Kinshasa, Zaire. Skin tests were read after 48-72 h. A reaction to an antigen was considered positive if there was induration of greater than 2 mm. Cutaneous anergy occurred more often in HIV-seropositive patients than in healthy controls (p less than 0.001) and was most prevalent in patients with advanced HIV illness. HIV-seropositive patients with a positive tuberculin reaction were more likely to have active tuberculosis (TB) than HIV-seropositive patients without a positive tuberculin reaction (p less than 0.001). Therefore, a TB diagnosis should be pursued in HIV-seropositive patients with a positive tuberculin reaction.

Entities:  

Mesh:

Year:  1989        PMID: 2585248

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  3 in total

Review 1.  HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.

Authors:  M C Raviglione; J P Narain; A Kochi
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

2.  Retrospective analysis of wound characteristics and tetanus development in captive macaques.

Authors:  Danielle A Springer; Kathrine Phillippi-Falkenstein; Gary Smith
Journal:  J Zoo Wildl Med       Date:  2009-03       Impact factor: 0.776

3.  Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.

Authors:  Timothy Lahey; Mecky Matee; Lillian Mtei; Muhammad Bakari; Kisali Pallangyo; C Fordham von Reyn
Journal:  BMC Infect Dis       Date:  2009-02-23       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.